Why the study?
Are maternal plasma endothelin-1 (ET-1) levels associated with clinical parameters in preeclampsia?
Are maternal plasma endothelin-1 (ET-1) levels associated with clinical parameters in preeclampsia?
Plasma endothelin-1 levels are elevated in preeclampsia and correlate with the severity of hypertensive disorders in pregnancy, suggesting a role in its pathophysiology.
This is the authors' abstract. We don't add key points for this paper.
Objective: To determine whether there are any asSociations between maternal plasma endothelin-1 (ET-1) levels and clinical parameters in pre-eclampsia.Methods: Blood samples were collected from 32 healthy pregnant women, 21 women with preeclampsia, and 11 women with gestational hypertension in the third trimester. ET-1 was measured by radioimmunoassay from Sep-Pak C18--extracted plasma.Results: The ET-1 levels were significantly higher in preeclamptic women [median 6.2 pmol/L (range 3.9–13.0)] than in healthy pregnant controls [4.8 pmol/L (1.8–6.8)], P < 0.0041. There was a positive correlation between plasma ET-1 levels and an umbilical arterial systolic/diastolic ratio (r = 0.42, P < 0.02) and an inverse, although statistically not significant, correlation between plasma ET-1 levels and platelet count (r = -0.35, P = 0.059) in women with preeclampsia and gestational hypertension.Conclusions: These findings suggest increased release of ET-1 in preeclampsia and an asSociation between the plasma ET-1 level and the severity of hypertensive disorder in pregnancy.
Answers are grounded in this paper and cite their sources.
ET-1 elevation may mark preeclampsia severity; hypothesis-generating for causal role and targeted therapies.
No takes yet. Share an insight, caveat, or question.
Pouta et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: